298 related articles for article (PubMed ID: 19382170)
1. Can we eliminate placebo in ALS clinical Trials?
Simmons Z
Muscle Nerve; 2009 Jun; 39(6):861-5. PubMed ID: 19382170
[TBL] [Abstract][Full Text] [Related]
2. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
Gordon PH
Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
[TBL] [Abstract][Full Text] [Related]
3. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].
Moriwaka F; Tashiro K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1258-60. PubMed ID: 11464472
[TBL] [Abstract][Full Text] [Related]
4. Selecting promising ALS therapies in clinical trials.
Cheung YK; Gordon PH; Levin B
Neurology; 2006 Nov; 67(10):1748-51. PubMed ID: 17130405
[TBL] [Abstract][Full Text] [Related]
5. [Glutamate antagonist].
Shindo M
No To Shinkei; 1998 Jul; 50(7):597-605. PubMed ID: 9739517
[No Abstract] [Full Text] [Related]
6. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
[TBL] [Abstract][Full Text] [Related]
8. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
Levy G; Kaufmann P; Buchsbaum R; Montes J; Barsdorf A; Arbing R; Battista V; Zhou X; Mitsumoto H; Levin B; Thompson JL
Neurology; 2006 Mar; 66(5):660-3. PubMed ID: 16534103
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of riluzole in amyotrophic lateral sclerosis.
Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
[TBL] [Abstract][Full Text] [Related]
10. Design of phase II ALS clinical trials.
Schoenfeld DA; Cudkowicz M
Amyotroph Lateral Scler; 2008; 9(1):16-23. PubMed ID: 18273715
[TBL] [Abstract][Full Text] [Related]
11. Riluzole for amyotrophic lateral sclerosis.
Med Lett Drugs Ther; 1995 Dec; 37(963):113-4. PubMed ID: 7500908
[No Abstract] [Full Text] [Related]
12. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY
Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372
[TBL] [Abstract][Full Text] [Related]
13. The value of database controls in pilot or futility studies in ALS.
Czaplinski A; Haverkamp LJ; Yen AA; Simpson EP; Lai EC; Appel SH
Neurology; 2006 Nov; 67(10):1827-32. PubMed ID: 17130417
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in ALS: an overview.
Turner MR; Parton MJ; Leigh PN
Semin Neurol; 2001 Jun; 21(2):167-75. PubMed ID: 11442325
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
[TBL] [Abstract][Full Text] [Related]
16. [Riluzole treatment in amyotrophic lateral sclerosis].
Wokke JH
Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2265-8. PubMed ID: 8984377
[No Abstract] [Full Text] [Related]
17. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
Dib M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
[TBL] [Abstract][Full Text] [Related]
19. [Tolerability of riluzole: a review of the literature].
Siniscalchi A
Clin Ter; 2004 Jan; 155(1):25-8. PubMed ID: 15147078
[TBL] [Abstract][Full Text] [Related]
20. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
